Navigation Links
Paul Hermes Joins Biorez Board of Directors

Biorez, Inc., a regenerative medicine company developing bioresorbable scaffold technology, today announced the election of Paul Hermes, Entrepreneur in Residence at Medtronic, Inc., to serve as an Independent Director on its Board of Directors.

Biorez has developed a proprietary, tissue-engineered scaffold for anterior cruciate ligament (ACL) reconstruction that is designed to stabilize the knee and facilitate regeneration of the ACL. The Biorez ACL implant is the first clinical application of its platform resorbable scaffold technology. The company is currently conducting preclinical studies and expects results in 2018.

“We are extremely pleased to announce the addition of Paul Hermes to our Board,” said Kevin Rocco, Biorez CEO. “Paul is a seasoned medical device executive with a strong history of commercializing new medical technologies. We expect that his experience, counsel, and leadership will be a great benefit to our team.”

Hermes will join existing board members Konstantine Drakonakis, Launch Capital; Richard Emmitt, The Vertical Group; Kevin Rocco, Biorez; and Dan Wagner, Connecticut Innovations. Hermes is currently Medtronic’s Entrepreneur in Residence responsible for the incubation of technologies to revolutionize the practice of surgery. He previously served as Chief Technology Officer, Vice President, Research and Development for Covidien’s Surgical Solutions segment. His teams have launched some of the medical device industry’s benchmark products, including the TriStaple™, iDrive™, SILS™, AbsorbaTack™ and LigaSure™ product lines.

Hermes added, “It is an exciting time to join Biorez as the company is conducting preclinical testing and preparing for human trials.”

Biorez’s product can be described as a synthetic ACL that incorporates into the body similar to autograft and allograft. Rocco further explained, “When a tissue graft is implanted into the body a lot of regenerative work happens, cells infiltrate the graft, new blood vessels form, and cells work to remodel structural proteins to meet the demands of the new environment. We have developed a synthetic graft that harnesses this process.”

Hermes is the holder of a number of US and international patents. He currently serves as the Chairman of the Board of Directors of the Connecticut Technology Council. He serves on the Advisory Board for the University of New Haven School of Arts and Sciences. He is a member of the Board of Directors at MindUP, the Digital Health Incubator, where he advises a number of startups and accelerators. Hermes has been honored with the highest technical honors of Covidien and Medtronic, the 2014 Covidien Chairman’s Lifetime Innovator Award and a 2015 induction into the Medtronic Bakken Society.

About Biorez, Inc.
Biorez, Inc. is a privately held early-stage regenerative medicine company engaged in developing bioresorbable scaffold implants to reconstruct and regenerate functional tissue in vivo. Its lead product candidate is an off-the-shelf implant for ACL reconstruction that spares harvesting of patient donor-tissue, and provides a better alternative to cadaver-based allograft. The company plans to commercialize its lead ACL technology, as well as expand its platform to new and innovative clinical applications. To learn more, visit

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related biology technology :

1. LumaCyte joins The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
2. Pacific Neuroscience Institute Medical Group Joins Providence Saint Johns Health Clinic For Greater Access to Care of Neurological and Cranial Disorders
3. Thirty-Year Marketing Veteran, David L. Politis, Joins ExcitePCR as its Chief Marketing & Sales Officer
4. John W. Sheets Jr., Former FDA Director Of The Office Of Device Evaluation, Joins NDA Partners As Expert Consultant
5. Excelera® Specialty Pharmacy Network Joins Merck’s Commitment to Hepatitis C
6. Tunnell Consulting Joins Top Industry Experts at ISPE Conference
7. Former VP of Clinical Pharmacology at Nektar Therapeutics, Michael A. Eldon, PhD, FCP, Joins NDA Partners as Expert Consultant
8. Wenyong Wang Joins Science Center as Vice President, Science & Technology
9. Biova Joins the Council for Responsible Nutrition
10. James B. (Jamie) Rogers Joins VIC Technology Venture Development™ Board of Directors
11. Former Associate Director of Product Development R&D at Allergan, Melissa Kirkegaard, joins NDA Partners as Expert Consultant
Post Your Comments:
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
(Date:10/9/2017)... ... , ... The award-winning American Farmer television series will feature 3 Bar Biologics ... at 8:30aET on RFD-TV. , With global population estimates nearing ten billion people ... to feed a growing nation. At the same time, many of our valuable resources ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... journal, Epilepsia, Brain Sentinel’s SPEAC® System which uses the surface electromyography (sEMG) ... tonic-clonic seizures (GTCS) using surface electromyography (sEMG). The prospective multicenter phase III ...
(Date:10/7/2017)...  The 2017 Nobel Prize in Chemistry recognizes ... Joachim Frank and Richard Henderson ... (cryo-EM) have helped to broaden the use ... The winners worked with systems manufactured by Thermo ... resolved, three-dimensional images of protein structures that lead ...
Breaking Biology Technology:
(Date:6/30/2017)... , June 30, 2017 Today, American ... and supplier of face and eye tracking software, ... Product provider program. "Artificial intelligence ... way to monitor a driver,s attentiveness levels while ... being able to detect fatigue and prevent potential ...
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... Report on Form 10-K on Thursday April 13, 2017 with the ... The ... section of the Company,s website at  under "SEC Filings," ... 2016 Year Highlights: Acquisition of ...
Breaking Biology News(10 mins):